Immune enhancement therapy: IFN-I increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene, 2/January/2017, 10.45 am

Natural product-based therapy for Metastatic tumors: Formononetin, an isoflavone found in the roots of astragalus membranaceus, Trifolium pratense, Glycyrrhiza glabra, and Pueraria lobata, increases the expression of metastasis suppressor gene TIMP-3 and inhibits invasion, migration and metastasis of tumor cells via down regulation of its target gene, 2/February/2017, 10.35 pm
February 2, 2017
Natural product-derived therapy for Metastatic human tumors: Brusatol, found in Brucea javanica (L) Merr. (Simaroubaceae), decreases the expression of c-Src protein, inhibits the expression of a number of enzymes in glycolytic cycle, and suppresses proliferation, migration, invasion, tumorigenesis and metastasis via up regulation of its target gene, 2/February/2017, 10.39 pm
February 2, 2017
Show all

Introduction: What they say:  

A recent study from the Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection.” This study was published in the 2 March 2015 issue of the Journal “Nature Immunology” [the number one journal in immunological research with an impact factor of  24.973] by Drs. Zusen Fan, Xia and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Immune enhancement therapy: Interferon-I (IFN-I) increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene


From Research Findings to Therapeutic Opportunity:

This study suggests, for the first time, that IFN-Iby decreasing the expression of its target gene, it may : (1) increase the expression of Sox2; (2) increase the ability of Sox2 to recognize bacterial DNA in cytoplasm; and (3) promote innate immunity against bacterial infection. 

price-50

Together, pharmacological formulations encompassing “IFN-I or its activators or IFN-I in combination with other drugs” may be used to (1) enhance innate immunity against bacterial infection; and (2) promote bacterial resistance (figs. 1-2). 


Details of the research findings

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information:

How IFN-I(1) enhances innate immunity against bacterial infection; and (2) promotes bacterial resistance?

Amount: $50

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L., Immune enhancement therapy: IFN-I increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene, 2/January/2017, 10.45 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.